{"id":31790,"date":"2026-07-07T16:30:00","date_gmt":"2026-07-07T14:30:00","guid":{"rendered":"http:\/\/stocks-future.com\/?guid=114e7b094fe18bc863f3490dc06fac68"},"modified":"2026-07-07T16:30:00","modified_gmt":"2026-07-07T14:30:00","slug":"tjp-expands-market-access-and-commercial-execution-capabilities-through-addition-of-fx2-virtual","status":"publish","type":"post","link":"https:\/\/stocks-future.com\/?p=31790","title":{"rendered":"TJP Expands Market Access and Commercial Execution Capabilities Through Addition of FX2 Virtual"},"content":{"rendered":"

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--TJP, an agency specializing in strategic, creative, and digital solutions for patient and market access teams as well as consumer brands, and portfolio company of Renovus Capital Partners, today announced its add-on of FX2 Virtual. FX2 Virtual is a specialized life sciences commercial operations agency led by pharmaceutical industry veterans Ed Kessig, Jeff Cino and Sal Paolozza that provides high-impact virtual sales professionals, patient access reimbursement support, and advanced omnichannel data analytics.<\/p><\/a><\/a>

\nThe addition of FX2 Virtual enables TJP to expand its life sciences capabilities from market and patient access strategy, patient journey design, and digital execution into virtual commercial deployment and field-level execution. Through FX2 Virtual\u2019s operational infrastructure, the combined entity now delivers specialized Virtual Sales Organizations and Virtual Key Account Managers (vKAMs) alongside its analytical data management, CRM optimization, and incentive compensation capabilities.<\/p>

\n\u201cBringing FX2 Virtual into the fold marks a pivotal evolution for TJP, allowing us to connect strategic insight with real-world, commercial pull-through,\u201d said Rino Mariconda, CEO of TJP. \u201cHistorically, we have excelled at designing the strategy-led creative, field enablement tools, and access intelligence that brands need to succeed. By adding a dedicated virtual sales force, virtual key account management team and data\/analytics, we can now directly drive the execution of that strategy, ensuring our life sciences partners achieve stronger adoption and pull-through in the market.\u201d<\/p>

\nFollowing the combination, FX2 Virtual will operate as a standalone brand under the TJP corporate umbrella, fully integrating its virtual commercial and analytical assets into TJP's core service offerings. The FX2 Virtual team will work alongside TJP\u2019s strategic and creative leaders to offer clients a single, unified partner capable of navigating complex access barriers while actively deploying field-level solutions.<\/p>

\n\u201cWe are thrilled to join forces with TJP and Renovus Capital to close the loop between access strategy and field execution,\u201d said Ed Kessig, Founding Partner FX2 Virtual. \u201cAligning our Virtual Sales Organizations and vKAM capabilities with TJP\u2019s expertise allows us to apply our skills where they matter most\u2014not just explaining the access pathway, but actively driving the brand adoption and ensuring patients receive the medicines they ultimately need.\u201d<\/p>

\nThe combined offerings perfectly complement one another by bridging the gap between strategy, tactical development, human pull-through and analytics\/measurement. While TJP provides the essential strategic foundation, value story harmonization, and tactical development, FX2 Virtual delivers the tactical sales teams and advanced operations analytics necessary to build, deploy, and maintain high-performing virtual field teams that maximize brand ROI and improve patient outcomes in the real world.<\/p>

\nFairmount Partners acted as exclusive adviser to FX2 Virtual.<\/p>

\nAbout TJP<\/b><\/p>

\nFounded in 1972 and recognized as an MM+M Top 100 Agency, TJP is a patient and market access agency specializing in strategic, creative, and digital solutions that align strategy, experience, and execution across the life sciences access ecosystem. Additionally, TJP delivers specialized, highly targeted marketing and digital solution offerings for consumer brands. For more information, visit https:\/\/tjpagency.com<\/a> and learn more about our consumer portfolio at https:\/\/tjpagency.com\/consumerbrands<\/a>.<\/p>

\nAbout FX2 Virtual<\/b><\/p>

\nFX2 Virtual is a premier commercial operations and virtual deployment agency led by pharmaceutical & biotech veterans Ed Kessig, Jeff Cino & Sal Paolozza with extensive industry experience. The firm delivers virtual sales forces, virtual key account management, patient reimbursement navigation, and precision data analytics to drive ROI and awareness for pharmaceutical brands. For more information, visit <\/b>https:\/\/fx2virtual.com<\/b><\/a>.<\/p>

\nAbout Renovus Capital Partners<\/b><\/p>

\nFounded in 2010, Renovus Capital Partners is a lower middle-market private equity firm specializing in the Knowledge and Talent industries. From its base in the Philadelphia area, Renovus manages over $2 billion of assets across its several sector focused funds. The firm's current portfolio includes over 30 U.S. based businesses specializing in education and workforce development and services companies in the technology, healthcare, and professional services markets. Renovus typically makes control buyout investments in founder owned businesses, leveraging its industry expertise and operator network to make operational improvements, recruit top talent and pursue add-on acquisitions. Visit us at www.renovuscapital.com<\/a> and follow us on LinkedIn<\/a>.<\/p>

\nAbout Fairmount Partners<\/b><\/p>

\nFairmount Partners is an independent mergers and acquisitions (\u201cM&A\u201d) advisory firm focused on supporting middle market companies to complete M&A transactions, raise capital, and execute their corporate development strategies. Fairmount\u2019s clients include successful entrepreneurs, private equity-sponsored enterprises, and global public companies. Since 2003, Fairmount has completed more than 325 transactions representing over $18 billion in aggregate value across 25 countries throughout North and South America, Asia, Australia, Europe, and the Middle East. For additional information, please visit www.fairmountpartners.com<\/a>.<\/p> Contacts<\/b>

\nMark Semer \/ Alex Jeffrey\nGasthalter & Co.\n(212) 257-4170\nRenovus@gasthalter.com<\/a><\/p>","protected":false},"excerpt":{"rendered":"

CONSHOHOCKEN, Pa.–(BUSINESS WIRE)–TJP, an agency specializing in strategic, creative, and digital solutions for patient and market access teams as well as consumer brands, and portfolio company of Renovus Capital Partners, today announced its add-on …<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-31790","post","type-post","status-publish","format-standard","hentry","category-infos-businesswire"],"_links":{"self":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/31790","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=31790"}],"version-history":[{"count":1,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/31790\/revisions"}],"predecessor-version":[{"id":31791,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/31790\/revisions\/31791"}],"wp:attachment":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=31790"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=31790"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=31790"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}